全球儿科重症加护市场

预计到 2030 年全球儿科重症加护市场规模将达到 368 亿美元

全球儿科重症加护市场规模预计在2024年达到279亿美元，预计在分析期（2024-2030年）内将以4.7%的复合年增长率增长，到2030年将达到368亿美元。呼吸系统疾病是本报告分析的细分市场之一，预计其复合年增长率将达到6.5%，到分析期结束时达到103亿美元。其他细分市场在分析期间内的复合年增长率预计为3.3%。

美国市场规模估计为 76 亿美元，中国市场预期复合年增长率为 8.9%

美国儿科重症加护市场规模预计2024年达到76亿美元。作为世界第二大经济体，中国预计到2030年市场规模将达到78亿美元，在2024年至2030年的分析期间内，复合年增长率为8.9%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为1.9%和3.8%。在欧洲，预计德国市场的复合年增长率为2.8%。

全球儿科重症加护市场—主要趋势与驱动因素摘要

为什么儿科重症加护是现代医学的重要前沿？

儿科重症加护是全球医疗保健领域资源最密集、技术主导和医学最复杂的专业之一。它涉及对患有危及生命疾病的婴儿、儿童和青少年进行严格监测和治疗，包括呼吸衰竭、败血症、创伤性脑损伤、先天性异常、心臟功能障碍和大手术的术后恢復。与成人加护病房不同，儿科加加护病房(PICU) 必须应对生理机能快速变化、器官系统不成熟以及体重相关药物剂量差异很大的挑战。 PICU 通常使用先进的生命维持系统，包括机械人工呼吸器、体外膜氧合 (ECMO)、持续性肾臟替代疗法 (CRRT) 和侵入性血流动力学监测设备，所有这些系统都是根据儿科生理机能量身体量身定制的。严重儿科患者的管理由于需要快速诊断、根据年龄调整镇静方案以及整合以家庭为中心的护理原则而变得更加复杂。全球趋势表明，由于早产儿、儿童创伤、先天性心臟疾病和慢性呼吸系统疾病的存活率不断上升，重症患者的负担日益加剧。这种临床压力正推动着儿科重症监护室（PICU）的扩张，尤其是在都市区医院、学术医疗中心和独立小儿科机构。专职儿科加护治疗和跨学科护理团队（包括药剂师、呼吸治疗师、营养师和儿童医疗辅导师）的存在反映了该领域的多维度。随着重症加护需求的增加，儿科病房正成为卫生政策和医院基础设施规划的首要重点。

科技进步如何改变儿科加加护病房？

儿科重症加护的转型得益于快速的技术创新，这些创新旨在提高维持生命干预的准确性、安全性和效率。具有新生儿和儿科模式的新一代人工呼吸器、可携式体外膜氧合 (ECMO) 系统以及整合病患监测平台正在成为先进儿科重症监护室 (PICU) 的标准配备。这些系统提供即时分析、预警评分和可自订的仪表板，使加护治疗能够快速做出数据驱动的决策。人工智慧 (AI) 和预测分析越来越多地被用于在患者病情恶化出现临床表现之前识别出来，尤其是在败血症和急性呼吸衰竭病例中。此外，床边超音波、快速血气分析仪和即时凝血监测仪等即时照护现场设备正在缩短治疗时间并改善紧急情况下的治疗效果。机器人技术和自动化药物输送系统也在重症加护工作流程中进行试点，以减少用药错误并确保输注速率的一致性，尤其是在血管压迫和镇静药物方面。穿戴式感测器和远端检测工具能够持续远端监测生命征象参数，支援医院和分级诊疗环境中的早期疗育。许多儿科重症监护室 (PICU) 现已配备集中式监测系统，允许在一个控制室观察和管理多名患者的数据。此外，电子健康记录(EHR)、临床决策支援工具和药物管理平台的数位整合正在简化业务，提高合规性并减少冗余。随着越来越多的医院投资云端基础和人工智慧的重症加护生态系统，未来的儿科重症监护室 (PICU) 不仅需要具备回应能力，还需要预测性、个人化和通讯协定驱动性。

为什么护理模式正在转向多学科、以家庭为中心的重症加护？

儿科重症加护服务正日益从孤立的临床干预模式转向整合的、多学科的、家庭包容性的护理模式。这项转变源自于人们意识到，在医疗治疗的同时，重症儿童的情绪、发展和社会心理需求也得到满足的环境中，他们的復原效果会更好。如今的儿科重症监护室 (PICU) 强调协作查房，让加护治疗专家、护士、社工、治疗师和家属参与护理讨论。这些团队合作制定治疗方案，充分考虑儿童的长期预后，并最大限度地降低小儿科加护治疗症候群 (PICS-p) 的风险，PICS-p 包括出院后的认知、情绪和身体障碍。针对先天性心臟疾病、创伤性脑损伤和多重器官衰竭等复杂疾病，正在实施专门的照护途径。医院也在投资建造包含游戏疗法、音乐疗法和教育的基础设施，以便全天候为家长提供服务，促进家属参与床边护理，减轻压力，并支持儿童的持续发展。随着非药物策略和经过验证的疼痛评估工具的应用日益广泛，儿科镇静和疼痛管理方案也日益精细化。在中低收入国家，结构化重症加护教育计画和远距PICU的日益普及，正在填补儿科重症加护专业知识的空白。此外，全球医疗保健组织正在透过集束化护理、模拟训练和协作式疗效登记等方式推进标准化，以确保重症加护监护的最佳实践。这种护理模式的全面转变不仅改善了临床疗效，也提升了年轻患者及其家属的体验和满意度。

儿科重症加护市场的成长受到多种因素的推动…

儿科重症加护市场的成长受到与技术创新、不断发展的最终用途动态以及消费者对医疗保健服务不断变化的期望有关的多种因素的驱动。一个关键驱动因素是需要密切监测和重症疾病发生率不断上升，包括新生儿併发症、创伤、呼吸道感染疾病和先天性心臟疾病。诊断影像、即时分析和儿科专用生命维持技术的进步使得更早发现和更有针对性地管理危重疾病成为可能，从而促使对先进儿科护理环境的投资。在最终用途方面，医院和卫生系统正在扩大 PICU 容量，将普通 ICU维修儿科用途，并在儿科医院内开发专门的重症加护大楼，以满足日益增长的需求。将儿科服务集中在三级和四级护理中心的趋势日益明显，从而创建提供高级重症监护的地理中心。同时，儿科转运团队、行动体外膜氧合 (ECMO) 服务和远距远端医疗加护治疗监护的兴起，正在扩大医疗资源匮乏地区的重症加护覆盖范围。消费者的期望也发挥关键作用，越来越多的家庭要求专业的儿科护理环境、更高的治疗决策透明度以及即时监测的参与度。同时，推动教育、基础设施标准化和疗效基准基准化分析的全球倡议正在提升全球医疗品质的基准。此外，设备製造商、医院系统和研究机构之间的合作正在加速儿科专用医疗设备和数位平台的开发。这些因素共同推动了儿科重症加护市场的持续扩张，并重新定义了其作为高效、富有同情心的儿科医疗保健体系基石的角色。

部分

治疗（呼吸系统、循环系统、神经系统、胃肠道、肌肉骨骼、感染疾病、血液疾病、先天性疾病、多重器官功能障碍症候群、其他）；医院所有权（公立/政府所有、非营利私营）

受访公司范例

• Abbott Laboratories
• Advin Health Care
• Baxter International Inc.
• Becton, Dickinson and Company（BD）
• Boston Scientific Corporation
• Compumedics Limited
• Cook Medical
• David Medical Device Co., Ltd.
• Dixion distribution of medical devices GmbH
• Dragerwerk AG & Co. KGaA
• Fritz Stephan GmbH
• GE Healthcare
• Hamilton Medical
• ICU Medical Inc.
• Koninklijke Philips NV
• Medtronic plc
• Nexxspan Healthcare
• Nice Neotech Medical Systems Pvt. Ltd.
• Terumo Corporation
• TSE MEDICAL

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地以及进出口情况（成品和原始OEM）预测其竞争地位的变化。这种复杂多变的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

• 市场概览
• 主要企业
• 市场趋势和驱动因素
• 全球市场展望

第三章市场分析

• 美国
• 加拿大
• 日本
• 中国
• 欧洲
• 法国
• 德国
• 义大利
• 英国
• 西班牙
• 俄罗斯
• 其他欧洲国家
• 亚太地区
• 澳洲
• 印度
• 韩国
• 其他亚太地区
• 拉丁美洲
• 阿根廷
• 巴西
• 墨西哥
• 其他拉丁美洲
• 中东
• 伊朗
• 以色列
• 沙乌地阿拉伯
• 阿拉伯聯合大公国
• 其他中东地区
• 非洲

第四章 竞赛

Global Pediatric Critical Care Market to Reach US$36.8 Billion by 2030

The global market for Pediatric Critical Care estimated at US$27.9 Billion in the year 2024, is expected to reach US$36.8 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Respiratory, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$10.3 Billion by the end of the analysis period. Growth in the Others segment is estimated at 3.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$7.6 Billion While China is Forecast to Grow at 8.9% CAGR

The Pediatric Critical Care market in the U.S. is estimated at US$7.6 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$7.8 Billion by the year 2030 trailing a CAGR of 8.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 3.8% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR.

Global Pediatric Critical Care Market - Key Trends & Drivers Summarized

What Makes Pediatric Critical Care a High-Stakes Frontier in Modern Medicine?

Pediatric critical care represents one of the most resource-intensive, technology-driven, and medically complex specialties in global healthcare. It encompasses the intensive monitoring and treatment of infants, children, and adolescents with life-threatening conditions, including respiratory failure, sepsis, traumatic brain injuries, congenital anomalies, cardiac dysfunctions, and post-operative recovery after major surgeries. Unlike adult critical care, pediatric intensive care units (PICUs) must contend with rapidly changing physiology, organ system immaturity, and highly variable weight-based drug dosing-challenges that demand specialized equipment, tailored treatment protocols, and highly trained personnel. PICUs typically operate with advanced life-support systems such as mechanical ventilators, extracorporeal membrane oxygenation (ECMO), continuous renal replacement therapy (CRRT), and invasive hemodynamic monitoring devices, all calibrated for pediatric physiology. The management of critically ill pediatric patients is further complicated by the need for rapid diagnostics, age-adjusted sedation protocols, and the integration of family-centered care principles. Global trends show a rising burden of pediatric critical illnesses due to increased survival of premature infants, pediatric trauma, congenital heart disease, and chronic respiratory conditions. These clinical pressures are driving the expansion of PICUs, particularly in urban hospitals, academic medical centers, and standalone pediatric facilities. The presence of dedicated pediatric intensivists and interdisciplinary care teams-including pharmacists, respiratory therapists, nutritionists, and child life specialists-reflects the multidimensional nature of this field. As critical care demands escalate, the pediatric segment is emerging as a frontline priority in both health policy and hospital infrastructure planning.

How Are Technological Advancements Reinventing Pediatric Intensive Care Units?

The transformation of pediatric critical care is being accelerated by rapid technological innovation aimed at enhancing precision, safety, and efficiency in life-sustaining interventions. Next-generation ventilators with neonatal and pediatric modes, portable ECMO systems, and integrated patient monitoring platforms are becoming standard across advanced PICUs. These systems offer real-time analytics, early warning scores, and customizable dashboards that allow intensivists to make faster, data-driven decisions. Artificial intelligence (AI) and predictive analytics are being increasingly used to identify patient deterioration before it becomes clinically apparent, particularly in sepsis and acute respiratory failure cases. In addition, point-of-care diagnostics, such as bedside ultrasound, rapid blood gas analyzers, and real-time coagulation monitors, are shortening time-to-treatment and improving outcomes in emergency situations. Robotics and automated drug delivery systems are also being piloted in critical care workflows to reduce medication errors and ensure consistent infusion rates, especially for vasopressors and sedatives. Wearable sensors and telemetry tools allow continuous remote monitoring of vital parameters, supporting early intervention in both in-hospital and step-down settings. Many PICUs are now implementing centralized monitoring systems where data from multiple patients can be observed and managed from a single control room. Furthermore, the digital integration of electronic health records (EHRs), clinical decision support tools, and medication management platforms has streamlined operations, improved compliance, and reduced redundancies. With hospitals increasingly investing in cloud-based and AI-enhanced critical care ecosystems, the PICU of the future is expected to be not only more responsive but also predictive, personalized, and protocol-driven.

Why Are Care Models Shifting Toward Multidisciplinary and Family-Centered Critical Care?

The delivery of pediatric critical care is increasingly shifting from siloed clinical interventions to integrated, multidisciplinary, and family-inclusive care models. This evolution is driven by the recognition that critically ill children recover better in environments where emotional, developmental, and psychosocial needs are addressed alongside medical treatment. Today’s PICUs emphasize collaborative rounds that include intensivists, nurses, social workers, therapists, and family members in care discussions. These teams work collectively to design treatment plans that account for the child’s long-term outcomes, minimizing the risk of post-intensive care syndrome in pediatrics (PICS-p), which includes cognitive, emotional, and physical impairments after PICU discharge. Specialized care pathways are being implemented for complex conditions such as congenital heart defects, traumatic brain injuries, and multi-organ failure, all requiring synchronized efforts from various specialists. Hospitals are also investing in infrastructure that accommodates parents around the clock, facilitates family participation in bedside care, and incorporates play therapy, music therapy, and education to reduce stress and support developmental continuity. Pediatric sedation and pain management protocols are becoming more nuanced, with greater use of non-pharmacological strategies and validated pain assessment tools. In low- and middle-income countries, the rise of structured critical care education programs and the use of tele-PICUs are bridging the gap in pediatric critical care expertise. Moreover, global health organizations are promoting standardization through care bundles, simulation training, and collaborative outcome registries to ensure best practices in critical care delivery. The holistic shift in care models is enhancing not only clinical outcomes but also the experience and satisfaction of both young patients and their families.

The Growth in the Pediatric Critical Care Market Is Driven by Several Factors…

The growth in the pediatric critical care market is driven by several factors related to technological innovation, evolving end-use dynamics, and shifting consumer expectations in healthcare delivery. One of the primary drivers is the increasing incidence of pediatric critical illnesses, including neonatal complications, traumatic injuries, respiratory infections, and congenital heart conditions, all of which require intensive monitoring and intervention. Advances in diagnostic imaging, real-time analytics, and pediatric-specific life-support technologies are enabling earlier recognition and more targeted management of critical conditions, prompting investments in high-acuity pediatric care settings. On the end-use front, hospitals and health systems are expanding their PICU capacities, retrofitting general ICUs for pediatric use, and developing specialized critical care wings within children’s hospitals to meet rising demand. The growing trend of centralizing pediatric services in tertiary and quaternary care institutions is creating geographic hubs for advanced critical care delivery. Simultaneously, the rise of pediatric transport teams, mobile ECMO services, and telemedicine-enabled intensive care is extending access to critical care in underserved regions. Consumer expectations are also playing a key role, with families increasingly advocating for child-specific care environments, greater transparency in treatment decisions, and involvement in real-time monitoring. In parallel, global initiatives promoting pediatric critical care education, infrastructure standardization, and outcome benchmarking are raising the baseline for care quality worldwide. Furthermore, collaborations between device manufacturers, hospital systems, and research institutions are accelerating the development of pediatric-focused medical equipment and digital platforms. These combined factors are fueling a sustained expansion of the pediatric critical care market and redefining its role as a cornerstone of high-performance, compassionate pediatric healthcare systems.

SCOPE OF STUDY:

The report analyzes the Pediatric Critical Care market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Treatment (Respiratory, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital, Multiple organ dysfunction syndrome, Others); Hospital Ownership (Publicly / Government-owned, Not-for-profit privately owned, For-profit privately owned)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Abbott Laboratories
• Advin Health Care
• Baxter International Inc.
• Becton, Dickinson and Company (BD)
• Boston Scientific Corporation
• Compumedics Limited
• Cook Medical
• David Medical Device Co., Ltd.
• Dixion distribution of medical devices GmbH
• Dragerwerk AG & Co. KGaA
• Fritz Stephan GmbH
• GE Healthcare
• Hamilton Medical
• ICU Medical Inc.
• Koninklijke Philips N.V.
• Medtronic plc
• Nexxspan Healthcare
• Nice Neotech Medical Systems Pvt. Ltd.
• Terumo Corporation
• TSE MEDICAL

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Pediatric Critical Care - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Severe Neonatal and Pediatric Conditions Propels Growth in Critical Care Infrastructure
  • Expansion of Pediatric Intensive Care Units (PICUs) Strengthens Business Case for Advanced Equipment
  • Increasing Availability of Pediatric Ventilators and Monitors Drives Technological Integration
  • Surge in Complex Pediatric Surgeries Throws the Spotlight on Perioperative Critical Care Needs
  • Improved Survival Rates Among Preterm Infants Accelerates Demand for Long-Term Intensive Support
  • Growing Burden of Pediatric Trauma and Acute Infections Sustains Demand for Critical Care Beds
  • Development of Specialized Pediatric Emergency Transport Systems Expands Access to Intensive Services
  • Integration of AI in Critical Care Monitoring Enhances Decision Support and Predictive Analytics
  • Proliferation of Pediatric ECMO Programs Drives Adoption of Advanced Life Support Technologies
  • Emphasis on Family-Centered Critical Care Models Strengthens Patient Outcomes and Facility Ratings
  • Increased Staffing of Pediatric Intensivists Spurs Efficiency and Quality of ICU Services
  • Rising Use of Smart Alarms and Automation Reduces Alert Fatigue in Pediatric ICUs
  • Growth in Pediatric Tele-ICU Programs Extends Reach of Critical Expertise to Remote Regions
  • Advancements in Non-Invasive Hemodynamic Monitoring Propel Precision in Pediatric Care Delivery
  • Expansion of Critical Care Training and Fellowship Programs Drives Workforce Readiness
  • Public Health Crises such as Pandemics Highlight Systemic Gaps and Spur Infrastructure Expansion
  • Innovations in Pediatric Sedation and Pain Management Enhance Comfort and Recovery Outcomes
  • Government Funding for Pediatric Health Systems Accelerates Procurement of ICU-Grade Equipment
  • Focus on Infection Control in Critical Settings Fuels Demand for Antimicrobial Surfaces and PPE
  • International Collaborations and Standardization Efforts Improve Quality and Consistency of Pediatric ICU Care
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Pediatric Critical Care Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Pediatric Critical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Pediatric Critical Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 4: World 15-Year Perspective for Pediatric Critical Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for Respiratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for Respiratory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 7: World 15-Year Perspective for Respiratory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Others by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 10: World 15-Year Perspective for Others by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 13: World 15-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 16: World 15-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 19: World 15-Year Perspective for Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for Musculoskeletal conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for Musculoskeletal conditions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 22: World 15-Year Perspective for Musculoskeletal conditions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Infection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Infection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 25: World 15-Year Perspective for Infection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Hematology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 28: World 15-Year Perspective for Hematology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 29: World Recent Past, Current & Future Analysis for Congenital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 30: World Historic Review for Congenital by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 31: World 15-Year Perspective for Congenital by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 32: World Recent Past, Current & Future Analysis for Multiple organ dysfunction syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 33: World Historic Review for Multiple organ dysfunction syndrome by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 34: World 15-Year Perspective for Multiple organ dysfunction syndrome by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 35: World Recent Past, Current & Future Analysis for Publicly / Government-owned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 36: World Historic Review for Publicly / Government-owned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 37: World 15-Year Perspective for Publicly / Government-owned by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 38: World Recent Past, Current & Future Analysis for Not-for-profit privately owned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 39: World Historic Review for Not-for-profit privately owned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 40: World 15-Year Perspective for Not-for-profit privately owned by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 41: World Recent Past, Current & Future Analysis for For-profit privately owned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 42: World Historic Review for For-profit privately owned by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 43: World 15-Year Perspective for For-profit privately owned by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 44: USA Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 45: USA Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 46: USA 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 47: USA Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 50: Canada Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 51: Canada Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 52: Canada 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 53: Canada Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 54: Canada Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 55: Canada 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• JAPAN
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 56: Japan Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Japan Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 58: Japan 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 59: Japan Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Japan Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 61: Japan 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• CHINA
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 62: China Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 63: China Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 64: China 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 65: China Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 66: China Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 67: China 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• EUROPE
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 68: Europe Recent Past, Current & Future Analysis for Pediatric Critical Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 69: Europe Historic Review for Pediatric Critical Care by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 70: Europe 15-Year Perspective for Pediatric Critical Care by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 71: Europe Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Europe Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 73: Europe 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 74: Europe Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 75: Europe Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 76: Europe 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• FRANCE
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 77: France Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 78: France Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 79: France 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 80: France Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 81: France Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 82: France 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• GERMANY
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 83: Germany Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 84: Germany Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 85: Germany 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 86: Germany Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Germany Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 88: Germany 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 89: Italy Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Italy Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 91: Italy 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 92: Italy Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Italy Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 94: Italy 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 95: UK Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 96: UK Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 97: UK 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 98: UK Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 99: UK Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 100: UK 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 101: Spain Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 102: Spain Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 103: Spain 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 104: Spain Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Spain Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 106: Spain 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 107: Russia Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Russia Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 109: Russia 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 110: Russia Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Russia Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 112: Russia 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 113: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Rest of Europe Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 115: Rest of Europe 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 116: Rest of Europe Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Rest of Europe Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 118: Rest of Europe 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 119: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Critical Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 120: Asia-Pacific Historic Review for Pediatric Critical Care by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 121: Asia-Pacific 15-Year Perspective for Pediatric Critical Care by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 122: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 123: Asia-Pacific Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 124: Asia-Pacific 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 125: Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 126: Asia-Pacific Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 127: Asia-Pacific 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 128: Australia Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 129: Australia Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 130: Australia 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 131: Australia Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Australia Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 133: Australia 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• INDIA
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 134: India Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 135: India Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 136: India 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 137: India Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 138: India Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 139: India 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 140: South Korea Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 141: South Korea Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 142: South Korea 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 143: South Korea Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 144: South Korea Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 145: South Korea 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 146: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Rest of Asia-Pacific Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 148: Rest of Asia-Pacific 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 149: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Asia-Pacific Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Asia-Pacific 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 152: Latin America Recent Past, Current & Future Analysis for Pediatric Critical Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 153: Latin America Historic Review for Pediatric Critical Care by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 154: Latin America 15-Year Perspective for Pediatric Critical Care by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 155: Latin America Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Latin America Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 157: Latin America 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 158: Latin America Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 159: Latin America Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 160: Latin America 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 161: Argentina Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Argentina Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 163: Argentina 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 164: Argentina Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Argentina Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 166: Argentina 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 167: Brazil Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Brazil Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 169: Brazil 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 170: Brazil Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Brazil Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 172: Brazil 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 173: Mexico Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Mexico Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 175: Mexico 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 176: Mexico Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Mexico Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 178: Mexico 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 179: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 180: Rest of Latin America Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 181: Rest of Latin America 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 182: Rest of Latin America Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 183: Rest of Latin America Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 184: Rest of Latin America 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 185: Middle East Recent Past, Current & Future Analysis for Pediatric Critical Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 186: Middle East Historic Review for Pediatric Critical Care by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 187: Middle East 15-Year Perspective for Pediatric Critical Care by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 188: Middle East Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 189: Middle East Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 190: Middle East 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 191: Middle East Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 192: Middle East Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 193: Middle East 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 194: Iran Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 195: Iran Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 196: Iran 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 197: Iran Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Iran Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 199: Iran 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 200: Israel Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Israel Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 202: Israel 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 203: Israel Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Israel Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 205: Israel 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 206: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 207: Saudi Arabia Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 208: Saudi Arabia 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 209: Saudi Arabia Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Saudi Arabia Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 211: Saudi Arabia 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 212: UAE Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 213: UAE Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 214: UAE 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 215: UAE Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 216: UAE Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 217: UAE 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 218: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Rest of Middle East Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 220: Rest of Middle East 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 221: Rest of Middle East Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Rest of Middle East Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 223: Rest of Middle East 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030
• AFRICA
  • Pediatric Critical Care Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 224: Africa Recent Past, Current & Future Analysis for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Africa Historic Review for Pediatric Critical Care by Treatment - Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 226: Africa 15-Year Perspective for Pediatric Critical Care by Treatment - Percentage Breakdown of Value Sales for Respiratory, Others, Cardiovascular, Neurology, Gastrointestinal, Musculoskeletal conditions, Infection, Hematology, Congenital and Multiple organ dysfunction syndrome for the Years 2015, 2025 & 2030
  • TABLE 227: Africa Recent Past, Current & Future Analysis for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Africa Historic Review for Pediatric Critical Care by Hospital Ownership - Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • TABLE 229: Africa 15-Year Perspective for Pediatric Critical Care by Hospital Ownership - Percentage Breakdown of Value Sales for Publicly / Government-owned, Not-for-profit privately owned and For-profit privately owned for the Years 2015, 2025 & 2030

IV. COMPETITION